Losigamone

Losigamone
Clinical data
ATC code	none;
Legal status
Legal status	Investigational;
Identifiers
	IUPAC name (2R)-2-[(S)-(2-chlorophenyl)-hydroxymethyl]-3-methoxy-2H-furan-5-one;
CAS Number	112856-44-7 ;
PubChem CID	6918049;
ChemSpider	5293266 ;
UNII	84R8O3QM2G;
Chemical and physical data
Formula	C12H11ClO4
Molar mass	254.67 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES Clc1ccccc1C(O)C2OC(=O)C=C2OC;
	InChI InChI=1S/C12H11ClO4/c1-16-9-6-10(14)17-12(9)11(15)7-4-2-3-5-8(7)13/h2-6,11-12,15H,1H3/t11-,12-/m0/s1 ; Key:ICDNYWJQGWNLFP-RYUDHWBXSA-N ;
	(what is this?) (verify)

ATC code

none

Legal status

Investigational

CAS Number

112856-44-7^N

PubChem CID

6918049

Losigamone (INN) is an investigational drug for the treatment of epilepsy. It has been studied as an add-on treatment for partial seizures.^[1] Phase III clinical trials were conducted around the year 2000.^[2]

[1]

[2]

Losigamone

References

Related Articles